#442534
Providers like you icon
Genentech USA #50242004164

Cathflo® Activase® Alteplase 2 mg Injection 2 mL

Name: Thrombolytic Agent
Brand: Cathflo® Activase®

CATHFLO, ACTIVASE 2MG VL

Cathflo® Activase® Alteplase 2 mg Injection 2 mL

Compare

Product Specifications

McKesson #

442534

Manufacturer #

50242004164

Brand

Cathflo® Activase®

Manufacturer

Genentech USA

Country of Origin

Unknown

Alternate Manufacturer Number

1642750

Application

Thrombolytic Agent

Container Type

Single-Use Vial

Dosage Form

Injection

Generic Drug Code

13922

Generic Drug Name

Alteplase

NDC Number

50242004164

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

2 mg

UNSPSC Code

51412702

Volume

2 mL

Features

Produced by recombinant DNA technology, Cathflo* is a fibrin-specific t-PA
Cathflo* is indicated for the restoration of function to central venous access devices (CVADs), as assessed by the ability to withdraw blood

More Information

MSDS

Professionals Also Viewed

View Full Comparison

#904182
Providers like you icon
Genentech USA #50242008527

Activase® Alteplase 100 mg Injection 58 Million IU

Activase is a tissue plasminogen activator (tPA) indicated for the tre …
Activase is proven to reduce disability in patients treated within 3 h …
Each 100 mg Activase vial (58 million IU) is packaged with diluent for …

No Image

#1168934
Providers like you icon
Genentech USA #50242012047

TNKASE® Tenecteplase 50 mg Injection

No Image

#1254782
Providers like you icon
Genentech USA #50242004110

Cathflo® Activase® Alteplase 2 mg Injection 2 mL

For Use in Central Venous Access Devices

#904177
Genentech USA #50242004413

Activase® Alteplase 50 mg Injection 29 Million IU

Activase® (alteplase) is indicated for the treatment of acute ischemic …
Activase® is indicated for use in acute myocardial infarction (AMI) fo …
Activase® is indicated for the lysis of acute massive pulmonary emboli …